Aurobindo Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE406A01037
  • NSEID: AUROPHARMA
  • BSEID: 524804
INR
1,713.40
-20.6 (-1.19%)
BSENSE

Sep 21, 02:29 PM

BSE+NSE Vol: 7.19 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 164981,
    "name": "Aurobindo Pharma",
    "stock_name": "Aurobindo Pharma",
    "full_name": "Aurobindo Pharma Ltd.",
    "name_url": "stocks-analysis/aurobindo-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,713.40",
    "chg": -20.6,
    "chgp": "-1.19%",
    "dir": -1,
    "prev_price": "1,734.00",
    "mcapval": "98,585.25 Cr",
    "mcap": "Mid Cap",
    "scripcode": 524804,
    "symbol": "AUROPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE406A01037",
    "curr_date": "Sep 21, 02:29 PM",
    "curr_time": "14:48 PM",
    "last_traded_at": "Sep 21, 02:29 PM IST",
    "bse_nse_vol": "7.19 lacs",
    "exc_status": "Active",
    "traded_date": "Sep 21, 2026",
    "traded_date_str": "2026 09 21",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aurobindo-pharma-164981-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Aurobindo Pharma Sees Significant Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-significant-open-interest-surge-amid-mixed-market-signals-4200043",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AurobindoPharma_oi_spurts_by_underlying_4200043.png",
        "date": "2026-09-21 14:00:07",
        "description": "Aurobindo Pharma Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.7% surge in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite this, the stock underperformed its sector and closed marginally lower, raising questions about the directional bets underpinning this spike in open interest."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Aurobindo Pharma Ltd. to 52-Week High of Rs 1739",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-hits-new-52-week-high-at-rs1739-4199823",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AurobindoPharma_priceRelatedfactors_4199823.png",
        "date": "2026-09-21 10:10:48",
        "description": "Surging to a fresh 52-week and all-time high of Rs 1739 on 21 Sep 2026, Aurobindo Pharma Ltd. has demonstrated remarkable price momentum, outperforming the broader market by a significant margin over the past year. This milestone caps a 54.49% rally from its 52-week low of Rs 1066, underscoring the stock’s sustained technical strength amid a mixed market backdrop."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Aurobindo Pharma Ltd. to 52-Week High of Rs 1707.9",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-hits-new-52-week-high-of-rs17079-on-18-sep-2026-4197685",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AurobindoPharma_priceRelatedfactors_4197685.png",
        "date": "2026-09-18 15:35:10",
        "description": "Surging past its previous peaks, Aurobindo Pharma Ltd. reached a new 52-week high of Rs 1707.9 on 18 Sep 2026, marking a remarkable 53.7% gain over the past year. This rally stands in stark contrast to the broader market, with the Sensex down 10.5% over the same period, underscoring the stock’s strong momentum despite a challenging environment."
      },
      {
        "title": "Aurobindo Pharma Ltd. is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aurobindo-pharma-ltd-is-rated-hold-by-marketsmojo-4193266",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AurobindoPharma_mojoScore_4193266.png",
        "date": "2026-09-15 10:10:51",
        "description": "Aurobindo Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 25 May 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 15 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Aurobindo Pharma Gains 0.20%: 4 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-gains-020-4-key-factors-driving-the-weeks-momentum-4192211",
        "imagepath": "",
        "date": "2026-09-13 15:00:41",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>31 Aug:</strong> New 52-week high at Rs.1,692.00</p>\n                    <p><strong>1 Sep:</strong> All-time high reached Rs.1,706.7</p>\n                    <p><strong>1 Sep:</strong> Sharp open interest surge amid mixed price signals</p>\n                    <p><strong>4 Sep:</strong> Week closes at Rs.1,653.30 (+0.20%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,650.00</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,653.30</div><div class=\"stat-change positive\">+0.20%</div..."
      },
      {
        "title": "Aurobindo Pharma Ltd. is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aurobindo-pharma-ltd-is-rated-hold-by-marketsmojo-4182386",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AurobindoPharma_mojoScore_4182386.png",
        "date": "2026-09-04 10:10:46",
        "description": "Aurobindo Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 September 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Aurobindo Pharma Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-sharp-open-interest-surge-amid-mixed-market-signals-4177979",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AurobindoPharma_oi_spurts_by_underlying_4177979.png",
        "date": "2026-09-01 12:00:07",
        "description": "Aurobindo Pharma Ltd. has witnessed a significant 21.6% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock underperformed its sector and traded in a narrow range close to its 52-week high, reflecting a complex interplay of bullish and cautious sentiments among traders."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Aurobindo Pharma Ltd. to 52-Week High of Rs 1706.7",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-hits-new-52-week-high-at-rs17067-4177322",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AurobindoPharma_priceRelatedfactors_4177322.png",
        "date": "2026-09-01 09:35:33",
        "description": "With a remarkable 64.8% gain over the past year, Aurobindo Pharma Ltd. surged to a fresh 52-week high of Rs 1706.7 on 1 Sep 2026, outpacing the Sensex which declined by 4.2% over the same period. This milestone underscores the stock’s sustained momentum amid a broader market that has been under pressure."
      },
      {
        "title": "Aurobindo Pharma Sees Sharp Open Interest Surge Amidst Bullish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-sharp-open-interest-surge-amidst-bullish-momentum-4176343",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AurobindoPharma_oi_spurts_by_underlying_4176343.png",
        "date": "2026-08-31 14:00:07",
        "description": "Aurobindo Pharma Ltd. has witnessed a notable surge in open interest in its derivatives segment, coinciding with robust price gains and sustained bullish momentum. The pharmaceutical giant’s stock hit a fresh 52-week high of Rs 1,684.7 on 31 Aug 2026, supported by a 13.3% increase in open interest, signalling heightened market participation and potential directional bets by traders."
      }
    ],
    "total": 867,
    "sid": "164981",
    "stock_news_url": "https://www.marketsmojo.com/news/aurobindo-pharma-164981"
  },
  "announcements": [
    {
      "details": "Aurobindo Pharma Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates",
      "source": "NSE",
      "caption": "Aurobindo Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates",
      "datetime": "28-Nov-2019"
    },
    {
      "details": "Aurobindo Pharma Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates",
      "source": "NSE",
      "caption": "Aurobindo Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates",
      "datetime": "15-Nov-2019"
    },
    {
      "details": "Aurobindo Pharma Limited has informed the Exchange regarding 'Completion of USFDA Inspection at our Unit IV Reg.,'.",
      "source": "NSE",
      "caption": "Aurobindo Pharma Limited - Updates",
      "datetime": "14-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aurobindo Pharma Ltd. has declared <strong>400%</strong> dividend, ex-date: 08 Aug 25",
          "dt": "2025-08-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Aurobindo Pharma Ltd. has announced <strong>1:5</strong> stock split, ex-date: 10 Feb 11",
          "dt": "2011-02-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Aurobindo Pharma Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 20 Jul 15",
          "dt": "2015-07-20",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Aurobindo Pharma Gains 0.20%: 4 Key Factors Driving the Week’s Momentum

2026-09-13 15:00:41

Key Events This Week

31 Aug: New 52-week high at Rs.1,692.00

1 Sep: All-time high reached Rs.1,706.7

1 Sep: Sharp open interest surge amid mixed price signals

4 Sep: Week closes at Rs.1,653.30 (+0.20%)

stock-recommendationAnnouncement

Aurobindo Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates

28-Nov-2019 | Source : NSE

Aurobindo Pharma Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

Aurobindo Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates

15-Nov-2019 | Source : NSE

Aurobindo Pharma Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

Aurobindo Pharma Limited - Updates

14-Nov-2019 | Source : NSE

Aurobindo Pharma Limited has informed the Exchange regarding 'Completion of USFDA Inspection at our Unit IV Reg.,'.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Aurobindo Pharma Ltd. has declared 400% dividend, ex-date: 08 Aug 25

stock-summary
SPLITS

Aurobindo Pharma Ltd. has announced 1:5 stock split, ex-date: 10 Feb 11

stock-summary
BONUS

Aurobindo Pharma Ltd. has announced 1:1 bonus issue, ex-date: 20 Jul 15

stock-summary
RIGHTS

No Rights history available